A

APT Medical Inc
SSE:688617

Watchlist Manager
APT Medical Inc
SSE:688617
Watchlist
Price: 411.89 CNY -0.27% Market Closed
Market Cap: 40B CNY
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one APT Medical Inc stock under the Base Case scenario is 269.5 CNY. Compared to the current market price of 411.89 CNY, APT Medical Inc is Overvalued by 35%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
269.5 CNY
Overvaluation 35%
Relative Value
Price
A
Worst Case
Base Case
Best Case

Valuation Multiples

20.4
P/S
P/S
Price to Sales
20.4
vs History
1
vs Industry
7
Median 3Y
15.9
Median 5Y
12.9
Industry
2.2
Forward
18.9
More Details
60.8
P/E
P/E
Price to Earnings
60.8
vs History
1
vs Industry
8
Median 3Y
49.9
Median 5Y
44.7
Industry
21.9
Forward
56.2
More Details
55
P/OCF
P/OCF
Price to OCF
55
vs History
1
vs Industry
6
Median 3Y
43.2
Median 5Y
39.6
Industry
13.5
More Details
1 474.3
P/FCFE
P/FCFE
Price to FCFE
1 474.3
vs History
7
vs Industry
0
Median 3Y
82.3
Median 5Y
59.8
Industry
19.3
More Details
16.8
P/B
P/B
Price to Book Value
16.8
vs History
1
vs Industry
2
Median 3Y
13.9
Median 5Y
10
Industry
2.1
More Details
20
EV/S
EV/S
Enterprise Value to Sales
20
vs History
1
vs Industry
7
Median 3Y
15.4
Median 5Y
12
Industry
2.3
Forward
18.5
More Details
28.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
28.1
vs History
1
vs Industry
7
Median 3Y
21.8
Median 5Y
17.1
Industry
4.8
More Details
54.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
54.9
vs History
1
vs Industry
6
Median 3Y
45.2
Median 5Y
40.1
Industry
11.5
Forward
45.9
More Details
54.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
54.9
vs History
1
vs Industry
8
Median 3Y
45.2
Median 5Y
40.1
Industry
15.6
Forward
48.3
More Details
53.9
EV/OCF
EV/OCF
Enterprise Value to OCF
53.9
vs History
1
vs Industry
6
Median 3Y
40.9
Median 5Y
36.4
Industry
13.3
More Details
375.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
375.6
vs History
1
vs Industry
2
Median 3Y
75.8
Median 5Y
61.8
Industry
17.3
More Details
22
EV/IC
EV/IC
Enterprise Value to IC
22
vs History
14
vs Industry
3
Median 3Y
19.1
Median 5Y
18.3
Industry
1.8
More Details

Multiples Across Competitors

Competitors Multiples
APT Medical Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
APT Medical Inc
SSE:688617
40.2B CNY 20.4 60.8 54.9 54.9
US
Abbott Laboratories
NYSE:ABT
230.4B USD 5.4 17.1 22.2 31.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.9B USD 21.7 76.3 60.9 73.3
US
Boston Scientific Corp
NYSE:BSX
153.5B USD 8.7 75.5 35.6 49.4
US
Stryker Corp
NYSE:SYK
144.3B USD 6.2 50.5 25 30.1
IE
Medtronic PLC
NYSE:MDT
105.6B USD 3.2 24.8 13.3 18.8
DE
Siemens Healthineers AG
XETRA:SHL
52.9B EUR 2.3 26.4 15.4 22
US
Becton Dickinson and Co
NYSE:BDX
47.3B USD 2.3 31.2 12.6 23.6
US
Edwards Lifesciences Corp
NYSE:EW
44.1B USD 8 10.5 24.1 26.5
US
IDEXX Laboratories Inc
NASDAQ:IDXX
38.2B USD 9.7 42.7 30.4 33.9
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
269.7B CNY 7.6 24.2 21.1 21.1

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 253,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.